Vaxart Operating Cycle from 2010 to 2026

VXRT Stock  USD 0.68  0.20  41.67%   
Vaxart Operating Cycle yearly trend continues to be comparatively stable with very little volatility. Operating Cycle will likely drop to 92.11 in 2026. From the period from 2010 to 2026, Vaxart Operating Cycle quarterly data regression had r-value of  0.20 and coefficient of variation of  67.69. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
137
Current Value
92.11
Quarterly Volatility
74.26319349
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.7 M, Interest Expense of 1.9 M or Total Revenue of 24.5 M, as well as many indicators such as Price To Sales Ratio of 9.61, Dividend Yield of 0.27 or PTB Ratio of 5.98. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Build AI portfolio with Vaxart Stock
Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Vaxart Inc over the last few years. It is Vaxart's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

Vaxart Operating Cycle Regression Statistics

Arithmetic Mean109.71
Geometric Mean83.00
Coefficient Of Variation67.69
Mean Deviation59.66
Median119.49
Standard Deviation74.26
Sample Variance5,515
Range267
R-Value0.20
Mean Square Error5,659
R-Squared0.04
Significance0.45
Slope2.87
Total Sum of Squares88,240

Vaxart Operating Cycle History

2026 92.11
2025 137.0
2024 152.22
2023 148.79
2022 291.67
2021 29.05
2020 34.16

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 137.00  92.11 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.